CLOs on the Move

IconOVir

www.iconovir.com

 
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O`Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iconovir.com
  • 4570 Executive Drive Suite 350
    San Diego, CA USA 92121
  • Phone: n/a

Executives

Name Title Contact Details

Similar Companies

Amunix

Amunix is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Talis Biomedical

ImmusanT

ImmusanT, Inc is a biotechnology company focused on developing a treatment, and a set of diagnostic and monitoring tools to manage patients with Celiac disease.

Canadian Bacterial Diseases Network (CBDN)

Canadian Bacterial Diseases Network (CBDN) is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

OvaScience

OvaScience (NASDAQ: OVAS) is a global fertility company dedicated to improving treatment options for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments because we believe women deserve more options. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPCSM) cells – immature egg cells found inside the protective ovarian lining.